Hip fracture risk in older US adults by treatment eligibility status based on new National Osteoporosis Foundation guidance

Osteoporosis International

Volumn 22, Issue 2, 2011, Pages 541-549

  Looker, A C ^a   Dawson Hughes, B ^a   Tosteson, A N A ^b   Johansson, H ^c   Kanis, J A ^c   Melton III, L J ^d  

^a TUFTS UNIVERSITY   (United States)

^b DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d MAYO CLINIC   (United States)

Author keywords

Incident hip fracture; National Osteoporosis Foundation Clinician's Guide; Population study; Treatment eligibility

Indexed keywords

AGE; AGED; AGING; ARTICLE; COHORT ANALYSIS; FEMALE; FEMUR NECK; GENDER; HEALTH SURVEY; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; OSTEOPOROSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED STATES;

AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HIP FRACTURES; HUMANS; LONGITUDINAL STUDIES; MALE; OSTEOPOROSIS; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 78651514080     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-010-1288-0     Document Type: Article

References (38)

1. National Osteoporosis Foundation. (2008) Clinician's guide to prevention and treatment of osteoporosis. In. National Osteoporosis Foundation, Washington, DC, pp 1-36
2. National Osteoporosis Foundation. (2005) Physician's Guide to Prevention and Treatment of Osteoporosis. In. Washington, DC
3. Kanis J (2008) Assessment of osteoporosis at the primary health-care level. In Group WHOS (ed). WHO Collaborating Centre, University of Sheffield
4. AN Tosteson LJ Melton 3rd B Dawson-Hughes S Baim MJ Favus S Khosla R Lindsay 2008 Cost-effective osteoporosis treatment thresholds: the United States perspective Osteoporos Int 19 437 447 1:STN:280:DC%2BD1c7nvF2ntg%3D%3D 18292976 10.1007/s00198-007-0550-6
5. B Dawson-Hughes A Looker A Tosteson H Johansson JA Kanis LJ Melton 2009 The potential impact of new National Osteoporosis Foundation guidance on treatment patterns Osteoporos Int 21 41 52 19705046 10.1007/s00198-009-1034-7
6. Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-94: series 1: programs and collection procedures. Vital Health Stat 1 (1994) 32:1-407
7. National Center for Health Statistics. Linkages among survey data from the National Center for Health Statistics and program data from the Centers for Medicare and Medicaid Services. Available at: http://www.cdc.gov/nchs/r&d/ nchs-datalinkage/data-linkage-cms.htm Accessed on 9/16/09
8. National Center for Health Statistics. The Third National Health and Nutrition Examination Survey (NHANES III) Linked Mortality File: Matching Methodology. December 2005. Available at: www.cdc.gov/nchs/r&d/nchs- datalinkage/nhanes-data-linkage-activities.htm. Accessed on 9/20/06
9. M Moon 1991 What Medicare has meant to older Americans Health Care Financ Rev 18 49 59
10. National Center for Health Statistics NCHS Definitions: Race. Available at http://www.cdc.gov/nchs/datawh/nchsdefs/race.htm. Accessed September 2, 2005
11. WA Ray MR Griffin RL Fought ML Adams 1992 Identification of fractures from computerized Medicare files J Clin Epidemiol 45 703 714 1:STN:280:DyaK38zhsl2lug%3D%3D 1619449 10.1016/0895-4356(92)90047-Q
12. AC Looker ME Mussolino 2008 Serum 25-hydroxyvitamin D and hip fracture risk in older U.S. white adults J Bone Miner Res 23 143 150 1:CAS:528: DC%2BD1cXhtVCmtLk%3D 17907920 10.1359/jbmr.071003
13. EB Lamont DS Lauderdale 2003 Low risk of hip fracture among elderly breast cancer survivors Ann Epidemiol 13 698 703 14599734 10.1016/S1047-2797(03) 00056-5
14. KM Sanders JA Pasco AM Ugoni GC Nicholson E Seeman TJ Martin B Skoric S Panahi MA Kotowicz 1998 The exclusion of high trauma fractures may underestimate the prevalence of bone fragility fractures in the community: the Geelong Osteoporosis Study J Bone Miner Res 13 1337 1342 1:STN:280:DyaK1czot1ehuw%3D%3D 9718203 10.1359/jbmr.1998.13.8.1337
15. JA Kanis H Johansson A Oden B Dawson-Hughes LJ Melton III EV McCloskey 2009 The effects of a FRAX® revision for the USA Osteoporos Int 21 35 40 10.1007/s00198-009-1033-8 19705047 10.1007/s00198-009-1033-8
16. B Ettinger DM Black B Dawson-Hughes AR Pressman LJ Melton 3rd 2009 Updated fracture incidence rates for the US version of FRAX® Osteoporos Int 21 25 33 10.1007/s00198-009-1032-9 19705048 10.1007/s00198-009-1032-9
17. B Dawson-Hughes ANA Tosteson LJ Melton 3rd S Baim MJ Favus S Khosla R Lindsay 2008 Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA Osteoporos Int 19 449 458 1:STN:280: DC%2BD1c7nvF2nsQ%3D%3D 18292975 10.1007/s00198-008-0559-5
18. Shah BV, Barnwell BG, Bieler GS (1995) SUDAAN User's Manual, Release 6.40. Research Triangle Institute, Research Triangle Park, NC
19. M Schemper J Stare 1996 Explained variation in survival analysis Stat Med 15 1999 2012 1:STN:280:DyaK2s%2FltFCjuw%3D%3D 8896135 10.1002/(SICI)1097- 0258(19961015)15:19<1999::AID-SIM353>3.0.CO;2-D
20. MG Donaldson PM Cawthon L-Y Lui JT Schousboe KE Ensrud BC Taylor JA Cauley TA Hillier DM Black DC Bauer SR Cummings for the Study of Osteoporotic Fractures 2009 Estimates of the proportion of older white women who would be recommended for pharmacologic treatment by the new U.S. National Osteoporosis Foundation Guidelines J Bone Miner Res 24 675 680 19049330 10.1359/jbmr.081203
21. JB Richards WD Leslie L Joseph K Siminoski DA Hanley JD Adachi JP Brown S Morin A Papaioannou RG Josse JC Prior KS Davison A Tenenhouse D Goltzman for the CaMos Study Group 2007 Changes to osteoporosis prevalence according to method of risk assessment J Bone Miner Res 22 228 234 17129177 10.1359/jbmr.061109
22. JA Kanis A Oden O Johnell H Johansson C De Laet J Brown P Burckhardt C Cooper C Christiansen S Cummings JA Eisman S Fujiwara C Gluer D Goltzman D Hans MA Krieg A La Croix E McCloskey D Mellstrom LJ Melton 3rd H Pols J Reeve K Sanders AM Schott A Silman D Torgerson T van Staa NB Watts N Yoshimura 2007 The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women Osteoporos Int 18 1033 1046 1:STN:280:DC%2BD2sznvV2hug%3D%3D 17323110 10.1007/s00198-007-0343-y
23. SR Cummings MC Nevitt WS Browner, et al. 1995 Risk factors for hip fracture in white women N Eng J Med 332 767 773 1:STN:280:DyaK2M7ms1aktw%3D%3D 10.1056/NEJM199503233321202
24. L Langsetmo D Goltzman C Kovacs, et al. 2009 Repeat low-trauma fractures occur frequently among men and women who have osteopenic BMD J Bone Miner Res 24 1515 1522 19338456 10.1359/jbmr.090319
25. M Espallargues L Sampietro-Colom MD Estrada M Sola L del Rio J Setoain A Granados 2001 Identifying bone-mass-related risk factors for fracture to guide bone densitometry measurements: a systematic review of the literature Osteoporos Int 12 811 822 1:STN:280:DC%2BD3MnntVCnsw%3D%3D 11716183 10.1007/s001980170031
26. WD Leslie JF Tsang LM Lix for the Manitoba Bone Density Program 2009 Simplified system for absolute fracture risk assessment: clinical validation in Canadian women J Bone Miner Res 24 353 360 19514851 10.1359/jbmr.081012
27. JA Kanis O Johnell A Oden A Dawson C De Laet B Jonsson 2001 Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds Osteoporos Int 12 989 995 1:STN:280:DC%2BD387hsValtQ%3D%3D 11846333 10.1007/s001980170006
28. J Robbins AK Aragaki C Kooperberg N Watts J Wactawski-Wende RD Jackson MS LeBoff CE Lewis Z Chen ML Stefanick J Cauley 2007 Factors associated with 5-year risk of hip fracture in postmenopausal women JAMA 298 2389 2398 1:CAS:528:DC%2BD2sXhtlyjtLrM 18042916 10.1001/jama.298.20.2389
29. DM Black M Steinbuch L Palermo P Dargent-Molina R Lindsay MS Hoseyni O Johnell 2001 An assessment tool for predicting fracture risk in postmenopausal women Osteoporos Int 12 519 528 1:STN:280:DC%2BD3MvosFagtQ%3D%3D 11527048 10.1007/s001980170072
30. P Dargent-Molina MN Douchin C Cormier PJ Meunier G Bréart for the EPIDOS Study Group 2002 Use of clinical risk factors in elderly women with low bone mineral density to identify women at higher risk of hip fracture: the EPIDOS Prospective Study Osteoporos Int 13 593 599 1:STN:280: DC%2BD38zmslSmtg%3D%3D 12111021 10.1007/s001980200078
31. CW McGrother MMK Donaldson D Clayton KR Abrams M Clarke 2002 Evaluation of a hip fracture risk score for assessing elderly women: the Melton Osteoporosis Fracture (MOF) study Osteoporos Int 13 89 96 1:STN:280: DC%2BD387ltFSqtA%3D%3D 11883411 10.1007/s198-002-8343-6
32. C MacLean S Newberry M Maglione M McMahon V Ranganath M Suttorp W Mojica M Timmer A Alexander M McNamara SB Desai A Zhou S Chen J Carter C Tringale D Valentine B Johnsen J Grossman 2008 Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis Ann Intern Med 148 197 213 18087050
33. JA Kanis A Oden H Johansson F Borgström O Ström E McCloskey 2009 FRAX® and its applications to clinical practice Bone 44 734 743 19195497 10.1016/j.bone.2009.01.373
34. JA Kanis O Johnell A Oden EV McCloskey 2008 FRAX® and the assessment of fracture probability in men and women from the UK Osteoporos Int 19 385 397 1:STN:280:DC%2BD1c7nvF2ntA%3D%3D 18292978 10.1007/s00198-007-0543-5
35. EV McCloskey H Johansson A Oden S Vasireddy K Kayan K Pande T Jalava JA Kanis 2009 Ten-year fracture probability identifies women who will benefit from clodronate therapy-additional results from a double-blind, placebo-controlled randomised study Osteoporos Int 20 811 817 1:CAS:528:DC%2BD1MXjvFaqt78%3D 19002369 10.1007/s00198-008-0786-9
36. JA Kanis H Johansson A Oden EV McCloskey 2009 Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX® Bone 44 49 54
37. R Burge B Dawson-Hughes DH Solomon JB Wong A King A Tosteson 2007 Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025 J Bone Miner Res 22 465 475 17144789 10.1359/jbmr.061113
38. NB Watts B Ettinger MS LeBoff 2009 FRAX facts J Bone Miner Res 24 975 979 19364271 10.1359/jbmr.090402